TLP

Tri Locum Partners Portfolio holdings

AUM $770M
1-Year Est. Return 78.21%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+78.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$770M
AUM Growth
+$335M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$76.3M
2
+$60.5M
3
+$59.4M
4
BSX icon
Boston Scientific
BSX
+$51M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$42M

Top Sells

1
+$37.5M
2
+$30.5M
3
+$20.8M
4
KRRO icon
Korro Bio
KRRO
+$16.2M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$14.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$575B
$125M 16.21%
603,143
+300,312
DHR icon
2
Danaher
DHR
$140B
$79.4M 10.31%
+346,875
LLY icon
3
Eli Lilly
LLY
$809B
$68M 8.83%
+63,284
UTHR icon
4
United Therapeutics
UTHR
$25.3B
$58.9M 7.65%
120,921
-1,266
ASND icon
5
Ascendis Pharma
ASND
$14.8B
$56.5M 7.34%
265,015
+90,186
MDGL icon
6
Madrigal Pharmaceuticals
MDGL
$11.9B
$50.1M 6.5%
86,023
+18,317
BSX icon
7
Boston Scientific
BSX
$96B
$49.6M 6.44%
+520,508
TEVA icon
8
Teva Pharmaceuticals
TEVA
$36.8B
$44.8M 5.82%
+1,435,865
IONS icon
9
Ionis Pharmaceuticals
IONS
$12.7B
$44.1M 5.72%
+557,174
VERA icon
10
Vera Therapeutics
VERA
$3.12B
$40.8M 5.3%
805,689
-384,518
AXSM icon
11
Axsome Therapeutics
AXSM
$9.42B
$36.8M 4.78%
201,627
-90,510
ARGX icon
12
argenx
ARGX
$52.3B
$31.7M 4.11%
37,653
-5,758
NUVL icon
13
Nuvalent
NUVL
$8.24B
$30.9M 4.01%
+307,371
DXCM icon
14
DexCom
DXCM
$23.7B
$28M 3.63%
+421,600
DNTH icon
15
Dianthus Therapeutics
DNTH
$5.21B
$25.6M 3.33%
622,403
+439,536
ABBV icon
16
AbbVie
ABBV
$369B
– –
-89,621
AVDL
17
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-724,859
BHVN icon
18
Biohaven
BHVN
$1.56B
– –
-149,179
KRRO icon
19
Korro Bio
KRRO
$197M
– –
-337,764
MRK icon
20
Merck
MRK
$291B
– –
-446,874
PRAX icon
21
Praxis Precision Medicines
PRAX
$9.47B
– –
-75,986
SLNO icon
22
Soleno Therapeutics
SLNO
$2.72B
– –
-450,585
STVN icon
23
Stevanato
STVN
$4.02B
– –
-332,912
TARS icon
24
Tarsus Pharmaceuticals
TARS
$3.06B
– –
-119,260
XENE icon
25
Xenon Pharmaceuticals
XENE
$5.62B
– –
-366,102